Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Moderate Senate Democrats seek bipartisan deal to end the month-long US government shutdown, as the impasse continues to impact millions.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Moderate Senate Democrats seek bipartisan deal to end the month-long US government shutdown, as the impasse continues to impact millions.